Bg pattern

TELFAST 120 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use TELFAST 120 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet: information for the user

Telfast 120 mg film-coated tablets

Fexofenadine hydrochloride

Read this leaflet carefully before starting to take this medicine, as it contains important information for you.

Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve after 7 days.

Contents of the leaflet

  1. What is Telfast and what is it used for
  2. What you need to know before taking Telfast
  3. How to take Telfast
  4. Possible side effects
  5. Storage of Telfast
  6. Package contents and additional information

1. What is Telfast and what is it used for

Telfast contains fexofenadine hydrochloride, which is a non-drowsy antihistamine.

Telfast 120 mg is used in adults and adolescents from 12 years of age to relieve symptoms associated with allergic rhinitis (such as hay fever), such as sneezing, itching, runny or stuffy nose, and itching, redness, and tearing of the eyes.

You should consult a doctor if it worsens or does not improve after 7 days.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Telfast

Do not take Telfast

  • If you are allergic to fexofenadine or any of the other components of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to take Telfast if:

  • you have liver or kidney problems.
  • you have or have had cardiovascular disease, as this medicine may cause a fast or irregular heartbeat.
  • you are an elderly patient.

If you are in any of these situations or are unsure, consult your doctor before taking Telfast.

Other medicines and Telfast

Tell your doctor or pharmacist if you are taking or have recently taken or may take any other medicine.

If you are taking apalutamide (a medicine for prostate cancer), as the effect of fexofenadine may decrease.

Indigestion remedies containing aluminum and magnesium may affect the action of Telfast, reducing the amount of medicine absorbed.

It is recommended to leave an interval of about 2 hours between taking Telfast and the indigestion remedy.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Do not take Telfast if you are pregnant, unless necessary.

Telfast is not recommended during breastfeeding.

Driving and using machines

It is very unlikely that Telfast will affect your ability to drive or operate machinery. However, you should make sure that when taking these tablets you do not feel drowsy or dizzy before driving or operating machinery.

Telfast contains sodium.

This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free".

3. How to take Telfast

Follow the administration instructions of this medicine as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist.

Adults and children from 12 years of age

The recommended dose is 1 tablet (120 mg) once a day.

Take the tablet with water before meals.

The effect of the medicine starts after 1 hour and lasts 24 hours.

If you take more Telfast than you should

If you take many tablets, consult your doctor or pharmacist, or go to the emergency department of the nearest hospital. The symptoms of overdose in adults are dizziness, drowsiness, fatigue, and dry mouth.

In case of overdose or accidental ingestion, consult the Toxicology Information Service (telephone 91 562 04 20).

If you forget to take Telfast

Do not take a double dose to make up for forgotten doses.

Take the next dose at the usual time indicated by your doctor.

If you stop taking Telfast

Consult your doctor if you want to stop taking Telfast before finishing the treatment. If you stop taking Telfast before planned, you may experience symptoms again.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.

Consult your doctor immediately and stop taking Telfast if you notice that:

  • your face, lips, tongue, or throat swell and you have difficulty breathing, as these may be symptoms of a severe allergic reaction.

The following unwanted effects have been reported in clinical trials, with an incidence similar to that observed in patients who did not receive the medicine (placebo).

Common side effects(may affect up to 1 in 10 people):

  • headache
  • drowsiness
  • feeling unwell (nausea)
  • dizziness.

Uncommon side effects(may affect up to 1 in 100 people):

  • fatigue / tendency to sleep

Other side effects(frequency not known: cannot be estimated from available data) that may occur are:

  • difficulty sleeping (insomnia)
  • sleep disorders
  • nightmares
  • nervousness
  • fast or irregular heartbeat
  • diarrhea
  • skin rash and itching
  • hives
  • severe allergic reactions that may cause swelling of the face, lips, tongue, or throat, shortness of breath, chest tightness, and difficulty breathing.
  • blurred vision.

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Telfast

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date shown on the packaging and blister after CAD. The expiration date is the last day of the month indicated.

This medicine does not require special storage conditions.

Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in your pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Telfast 120 mg

The active ingredient is fexofenadine hydrochloride. Each film-coated tablet contains 120 mg of fexofenadine hydrochloride.

The other ingredients are:

Core components: microcrystalline cellulose, pregelatinized corn starch, sodium croscarmellose, magnesium stearate.

Coating components: hypromellose, povidone, titanium dioxide (E171), colloidal anhydrous silica, macrogol, and red iron oxide (E 172) and yellow iron oxide (E172).

Appearance of the product and package contents

Telfast 120 mg are film-coated tablets, 6.1 x 15.8 mm in size, oblong in shape, and pale orange in color, engraved with "012" on one side and an "e" written on the other side.

Telfast is available in blisters. Each tablet is inside the blister.

Telfast is available in packs of 2 (only samples), 7, 10, 15, 20, 30, 50, 100, and 200 (10x20) tablets per pack.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Opella Healthcare Spain, S.L.

C/ Roselló i Porcel, 21

08016 - Barcelona

Spain

Sanofi Group

Manufacturer

Sanofi-Winthrop Industrie

Avenue Gustave Eiffel, 30 – 36

Tours (France)

or

Opella Healthcare International SAS

56, route de Choisy

60200 Compiègne (France)

This medicine is authorized in the Member States of the European Economic Area under the following names:

Austria: Allegra 120 mg Filmtabletten

Belgium: Allegratab 120 mg filmomhulde tabletten

Croatia: Allegra 120 mg filmom obložene tablete

Denmark: Telfast, filmovertrukne tabletter 120 mg

Finland: Telfast 120 mg tabletti, kalvopäällysteinen

Germany: Telfast 120 mg-Filmtabletten

Greece: Allegra

Ireland: Telfast 120 mg film-coated tablets

Italy: Telfast 120 mg compresse rivestite con film

Luxembourg: Allegratab 120 mg comprimés pelliculés

Malta: Telfast 120 mg film-coated Tablets

Portugal: Telfast 120, comprimidos revestidos por película

Slovenia: Telfast 120 mg filmsko obložene tablete

Spain: Telfast 120 mg comprimidos recubiertos con película

Sweden: Allegra

United Kingdom: Telfast 120 mg film-coated tablets

Date of the last revision of this leaflet:September 2023

You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/61910/P_61910.html

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for TELFAST 120 mg FILM-COATED TABLETS

Discuss questions about TELFAST 120 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for TELFAST 120 mg FILM-COATED TABLETS?
TELFAST 120 mg FILM-COATED TABLETS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in TELFAST 120 mg FILM-COATED TABLETS?
The active ingredient in TELFAST 120 mg FILM-COATED TABLETS is fexofenadine. This information helps identify medicines with the same composition but different brand names.
Who manufactures TELFAST 120 mg FILM-COATED TABLETS?
TELFAST 120 mg FILM-COATED TABLETS is manufactured by Opella Healthcare Spain S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of TELFAST 120 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether TELFAST 120 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to TELFAST 120 mg FILM-COATED TABLETS?
Other medicines with the same active substance (fexofenadine) include FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS, FEXOFENADINE CIPLA 180 mg FILM-COATED TABLETS, FEXOFENADINE OPELLA 180 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media